Session Information

Filter Results:

Show Only CME Accredited Sessions

  • +

    P2.04 - Clinical Design, Statistics and Clinical Trials

    • 09:30 - 16:00
    • 10/17/2017
    • Location: Exhibit Hall (Hall B + C)
    • Type: Poster Session with Presenters Present
    • Track: Clinical Design, Statistics and Clinical Trials
    • +

      P2.04-007 - KEYNOTE-604: Phase 3 Randomized, Double-Blind Trial of Pembrolizumab/Placebo plus Etoposide/Platinum for Extensive Stage-SCLC

      09:30 - 09:30  |  Presenter: Charles M Rudin  |  Author(s): L. Shen, M.C. Pietanza

      • Abstract

      Loading...

  • +

    MA 07 - ALK, ROS and HER2

    • 15:45 - 17:30
    • 10/17/2017
    • Location: Room 316
    • Type: Mini Oral
    • Track: Advanced NSCLC
    • +

      MA 07.04 - Clinical Impact of Crizotinib on Brain Metastases in Patients with Advanced ROS1-Rearranged Non-Small Cell Lung Cancer

      16:00 - 16:05  |  Presenter: Shun Lu  |  Author(s): L. Shen

      • Abstract

      Loading...